Exane Derivatives’s Marsh MRSH Stock Holding History

Exane Derivatives’s Portfolio MRSH Stock Details MRSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,700	Closed	-$863K	–	932
2021 Q3	$863K	Buy	+5,700	New	+$862K	0.21%	102

Other funds holding MRSH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's MRSH Position: Q4 2021 in Review

Exane Derivatives sold out of Marsh (MRSH) in Q4 2021, closing a stake of 5,700 shares — an estimated $863K sold.

Exane Derivatives first reported a position in MRSH in Q3 2021 and held it in 1 quarter. The position peaked at $863K in Q3 2021. 1,167 funds tracked by Wall St. Rank hold MRSH as of Q4 2021.

Exane Derivatives reported no remaining Marsh position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 5,700 Marsh shares in Q4 2021, an estimated $863K.
Exane Derivatives first reported a position in Marsh in Q3 2021 and held it in 1 quarter.
Exane Derivatives's Marsh position peaked at $863K in Q3 2021.
1,167 funds tracked by Wall St. Rank held Marsh as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.